Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Abatacept to Treat Steroid Refractory Chronic Graft Versus Host Disease (cGVHD)

Phase 1

Completed

Conditions: Chronic Graft Versus Host Disease

Interventions: Drug: Abatacept

First Posted Date: 2013-10-07

Last Posted Date: 2024-01-18

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 56

Registration Number: NCT01954979

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Ubiquinol (Reduced COQ10) for Patients With Sepsis

Phase 2

Completed

Conditions: Sepsis

Interventions: Dietary Supplement: Placebo
Drug: Ubiquinol

First Posted Date: 2013-09-23

Last Posted Date: 2017-04-24

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 38

Registration Number: NCT01948063

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Pathogenic Mechanisms in C Diff Infection and Colitis

Completed

Conditions: Clostridium Difficile Infection

First Posted Date: 2013-08-28

Last Posted Date: 2017-03-08

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 24

Registration Number: NCT01930032

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Pulmonary Vascular Effects of Respiratory Rate & Carbon Dioxide

Not Applicable

Withdrawn

Conditions: Acute Respiratory Distress Syndrome
Low Tidal Volume Ventilation

Interventions: Other: HLR
Other: EHR

First Posted Date: 2013-08-22

Last Posted Date: 2017-02-27

Lead Sponsor: Beth Israel Deaconess Medical Center

Registration Number: NCT01927237

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Fostering Eating After Stroke With Transcranial Direct Current Stimulation

Not Applicable

Completed

Conditions: Dysphagia
Stroke

Interventions: Device: tDCS

First Posted Date: 2013-08-08

Last Posted Date: 2020-07-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 42

Registration Number: NCT01919112

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Response to Supplement and Placebo in GERD

Not Applicable

Completed

Conditions: Gastroesophageal Reflux Disease (GERD)
Heartburn
Dyspepsia

Interventions: Drug: Placebo
Drug: Supplement
Behavioral: Expanded Interview
Behavioral: Standard Interview

First Posted Date: 2013-08-02

Last Posted Date: 2017-03-29

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 24

Registration Number: NCT01915173

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Immune Response in Celiac Disease on In-vitro Gluten Challenge

Completed

Conditions: Celiac Disease

First Posted Date: 2013-07-26

Last Posted Date: 2018-03-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 42

Registration Number: NCT01909050

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Celiac Disease Screening

Not Applicable

Terminated

Conditions: Celiac Disease

Interventions: Other: gluten free diet

First Posted Date: 2013-07-18

Last Posted Date: 2018-03-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 14

Registration Number: NCT01902368

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

Not Applicable

Recruiting

Conditions: Renal Cell Carcinoma

Interventions: Device: CyberKnife

First Posted Date: 2013-07-02

Last Posted Date: 2024-08-15

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 46

Registration Number: NCT01890590

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Sleep Effectiveness and Insulin and Glucose Homeostasis

Phase 1

Terminated

Conditions: Glucose Intolerance
Prediabetic
Diabetes
Prediabetes

Interventions: Drug: eszopiclone

First Posted Date: 2013-06-27

Last Posted Date: 2019-12-19

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 20

Registration Number: NCT01887691

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy